Accelmed is a growth-oriented investment firm specializing in HealthTech companies, leveraging proprietary technologies and data analysis to support clinical trials and patient care. Founded in 2009, the firm manages private equity funds and invests in commercial-stage companies, with notable achievements in digital therapeutics and medical device sectors.
Leadership
| Name | Title | ||
|---|---|---|---|
| Steve Rubin | Partner |
in/steve-rubin-05054a37
|
|
| Vice President |
|
|
|
| Venture Partner |
|
|
|
| Founder | Managing Partner |
|
|
|
| Venture Partner |
|
|
Recent Transactions involving Accelmed
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Veranex Acquires Leading Pathology and Histology Provider HORUS Scientific |
HORUS Scientific |
Veranex |
Summit PartnersAccelmedLauxera Capital Partners |
Histopathology Services |
|
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →